HC Wainwright & Co. Reiterates Buy on Curis, Maintains $17 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.8%

Neg 0% Neu 88.8% Pos 0%

HC Wainwright & Co. analyst Sara Nik reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $17 price target.

Comments

No comments yet. Be the first!

HC Wainwright &amp; Co. Reiterates Buy on Curis, Maintains $17 Price Target